NORPACE CR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norpace Cr, and when can generic versions of Norpace Cr launch?
Norpace Cr is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in NORPACE CR is disopyramide phosphate. There are nineteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the disopyramide phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Norpace Cr
A generic version of NORPACE CR was approved as disopyramide phosphate by TEVA on February 22nd, 1985.
Summary for NORPACE CR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 47 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,247 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for NORPACE CR |
| DailyMed Link: | NORPACE CR at DailyMed |
Recent Clinical Trials for NORPACE CR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Medtronic | Phase 3 |
| Mayo Clinic | Phase 3 |
Pharmacology for NORPACE CR
| Drug Class | Antiarrhythmic |
Anatomical Therapeutic Chemical (ATC) Classes for NORPACE CR
US Patents and Regulatory Information for NORPACE CR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | NORPACE CR | disopyramide phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 018655-001 | Jul 20, 1982 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Pfizer | NORPACE CR | disopyramide phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 018655-002 | Jul 20, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
